These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1058 related items for PubMed ID: 11896113

  • 1. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C, Klersy C, Barbarano L, Nosari AM, Crugnola M, Pungolino E, Gargantini L, Granata S, Valentini M, Morra E.
    J Clin Oncol; 2002 Mar 15; 20(6):1625-34. PubMed ID: 11896113
    [Abstract] [Full Text] [Related]

  • 2. Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.
    Morra E, Cesana C, Klersy C, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Barbarano L, Lazzarino M, Hematology/Oncology Studies and Trials (HOST) Group, Italy.
    Semin Oncol; 2003 Apr 15; 30(2):172-7. PubMed ID: 12720131
    [Abstract] [Full Text] [Related]

  • 3. Clinical characteristics and factors predicting evolution of asymptomatic IgM monoclonal gammopathies and IgM-related disorders.
    Morra E, Cesana C, Klersy C, Barbarano L, Varettoni M, Cavanna L, Canesi B, Tresoldi E, Miqueleiz S, Bernuzzi P, Nosari AM, Lazzarino M.
    Leukemia; 2004 Sep 15; 18(9):1512-7. PubMed ID: 15322559
    [Abstract] [Full Text] [Related]

  • 4. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L, Fernández de Larrea C, Elena M, Cibeira MT, Tovar N, Aróstegui JI, Pedrosa F, Rosiñol L, Filella X, Yagüe J, Bladé J.
    Clin Lymphoma Myeloma Leuk; 2016 Jun 15; 16(6):e71-7. PubMed ID: 27013181
    [Abstract] [Full Text] [Related]

  • 5. Addition of Rice Bran Arabinoxylan to Curcumin Therapy May Be of Benefit to Patients With Early-Stage B-Cell Lymphoid Malignancies (Monoclonal Gammopathy of Undetermined Significance, Smoldering Multiple Myeloma, or Stage 0/1 Chronic Lymphocytic Leukemia): A Preliminary Clinical Study.
    Golombick T, Diamond TH, Manoharan A, Ramakrishna R.
    Integr Cancer Ther; 2016 Jun 15; 15(2):183-9. PubMed ID: 27154182
    [Abstract] [Full Text] [Related]

  • 6. Factors predicting transformation of asymptomatic IgM monoclonal gammopathy.
    Greco A, Tedeschi A, Varettoni M, Nichelatti M, Paris L, Ricci F, Vismara E, Morra E.
    Clin Lymphoma Myeloma Leuk; 2011 Feb 15; 11(1):77-9. PubMed ID: 21454196
    [Abstract] [Full Text] [Related]

  • 7. IgM monoclonal gammopathy of undetermined significance (MGUS) and smoldering Waldenström's macroglobulinemia (SWM).
    Kyle RA, Dispenzieri A, Kumar S, Larson D, Therneau T, Rajkumar SV.
    Clin Lymphoma Myeloma Leuk; 2011 Feb 15; 11(1):74-6. PubMed ID: 21454195
    [Abstract] [Full Text] [Related]

  • 8. Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.
    Baldini L, Guffanti A, Cesana BM, Colombi M, Chiorboli O, Damilano I, Maiolo AT.
    Blood; 1996 Feb 01; 87(3):912-8. PubMed ID: 8562962
    [Abstract] [Full Text] [Related]

  • 9. A long-term study of prognosis in monoclonal gammopathy of undetermined significance.
    Kyle RA, Therneau TM, Rajkumar SV, Offord JR, Larson DR, Plevak MF, Melton LJ.
    N Engl J Med; 2002 Feb 21; 346(8):564-9. PubMed ID: 11856795
    [Abstract] [Full Text] [Related]

  • 10. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
    Viera S, Ludek P, Zdeněk A, Marta K, Martin Š, Sabina Š, Zdeněk K.
    Klin Onkol; 2018 Feb 21; 31(4):270-276. PubMed ID: 30541309
    [Abstract] [Full Text] [Related]

  • 11. Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: proposal for a common prognostic scoring system.
    Baldini L, Goldaniga M, Guffanti A, Broglia C, Cortelazzo S, Rossi A, Morra E, Colombi M, Callea V, Pogliani E, Ilariucci F, Luminari S, Morel P, Merlini G, Gobbi P.
    J Clin Oncol; 2005 Jul 20; 23(21):4662-8. PubMed ID: 16034042
    [Abstract] [Full Text] [Related]

  • 12. Clinical characteristics and outcome of immunoglobulin M-related disorders.
    Cesana C, Barbarano L, Miqueleiz S, Lucchesini C, Ricci F, Varettoni M, Filippini D, Lazzarino M, Morra E.
    Clin Lymphoma; 2005 Mar 20; 5(4):261-4. PubMed ID: 15794861
    [Abstract] [Full Text] [Related]

  • 13. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV, Harris S, Dispenzieri A, Cosio FG, Habermann TM, Stegall MD, Dean PG, Prieto M, Kyle RA, Rajkumar SV, Leung N.
    Am J Nephrol; 2012 Mar 20; 35(4):365-71. PubMed ID: 22473253
    [Abstract] [Full Text] [Related]

  • 14. Prognostic factors for transformation in asymptomatic immunoglobulin m monoclonal gammopathies.
    Morra E, Cesana C, Klersy C, Barbarano L, Miqueleiz S, Varettoni M, Lucchesini C, Ricci F, Lazzarino M.
    Clin Lymphoma; 2005 Mar 20; 5(4):265-9. PubMed ID: 15794862
    [Abstract] [Full Text] [Related]

  • 15. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
    Montoto S, Rozman M, Rosiñol L, Nadal E, Giné E, Aymerich M, Ferrer A, Esteve J, Bosch F, López-Guillermo A, Bladé J, Montserrat E.
    Semin Oncol; 2003 Apr 20; 30(2):178-81. PubMed ID: 12720132
    [Abstract] [Full Text] [Related]

  • 16. Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance.
    Blade J, Lopez-Guillermo A, Rozman C, Cervantes F, Salgado C, Aguilar JL, Vives-Corrons JL, Montserrat E.
    Br J Haematol; 1992 Jul 20; 81(3):391-4. PubMed ID: 1390212
    [Abstract] [Full Text] [Related]

  • 17. Smoldering multiple myeloma and monoclonal gammopathy of undetermined significance.
    Bladé J, Rosiñol L.
    Curr Treat Options Oncol; 2006 May 20; 7(3):237-45. PubMed ID: 16615879
    [Abstract] [Full Text] [Related]

  • 18. Monoclonal gammopathy of undetermined significance.
    Kyle RA.
    Blood Rev; 1994 Sep 20; 8(3):135-41. PubMed ID: 7819815
    [Abstract] [Full Text] [Related]

  • 19. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z, Krejčí M, Pour L, Sevčíková E, Křivanová A, Rehák Z, Koukalová R, Cermáková Z, Vaníček J, Sevčíková S.
    Vnitr Lek; 2014 Oct 20; 60(10):861-79. PubMed ID: 25382009
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 53.